Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation
- PMID: 37202507
- PMCID: PMC10244277
- DOI: 10.1007/s00125-023-05914-7
Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation
Abstract
Aims/hypothesis: Several studies have identified associations between type 2 diabetes and DNA methylation (DNAm). However, the causal role of these associations remains unclear. This study aimed to provide evidence for a causal relationship between DNAm and type 2 diabetes.
Methods: We used bidirectional two-sample Mendelian randomisation (2SMR) to evaluate causality at 58 CpG sites previously detected in a meta-analysis of epigenome-wide association studies (meta-EWAS) of prevalent type 2 diabetes in European populations. We retrieved genetic proxies for type 2 diabetes and DNAm from the largest genome-wide association study (GWAS) available. We also used data from the Avon Longitudinal Study of Parents and Children (ALSPAC, UK) when associations of interest were not available in the larger datasets. We identified 62 independent SNPs as proxies for type 2 diabetes, and 39 methylation quantitative trait loci as proxies for 30 of the 58 type 2 diabetes-related CpGs. We applied the Bonferroni correction for multiple testing and inferred causality based on p<0.001 for the type 2 diabetes to DNAm direction and p<0.002 for the opposing DNAm to type 2 diabetes direction in the 2SMR analysis.
Results: We found strong evidence of a causal effect of DNAm at cg25536676 (DHCR24) on type 2 diabetes. An increase in transformed residuals of DNAm at this site was associated with a 43% (OR 1.43, 95% CI 1.15, 1.78, p=0.001) higher risk of type 2 diabetes. We inferred a likely causal direction for the remaining CpG sites assessed. In silico analyses showed that the CpGs analysed were enriched for expression quantitative trait methylation sites (eQTMs) and for specific traits, dependent on the direction of causality predicted by the 2SMR analysis.
Conclusions/interpretation: We identified one CpG mapping to a gene related to the metabolism of lipids (DHCR24) as a novel causal biomarker for risk of type 2 diabetes. CpGs within the same gene region have previously been associated with type 2 diabetes-related traits in observational studies (BMI, waist circumference, HDL-cholesterol, insulin) and in Mendelian randomisation analyses (LDL-cholesterol). Thus, we hypothesise that our candidate CpG in DHCR24 may be a causal mediator of the association between known modifiable risk factors and type 2 diabetes. Formal causal mediation analysis should be implemented to further validate this assumption.
Keywords: Causality; DNA methylation; Epigenetics; Mendelian randomisation; Type 2 diabetes.
© 2023. The Author(s).
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10244277/bin/125_2023_5914_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10244277/bin/125_2023_5914_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10244277/bin/125_2023_5914_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10244277/bin/125_2023_5914_Fig4_HTML.gif)
Similar articles
-
Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts.Diabetologia. 2022 May;65(5):763-776. doi: 10.1007/s00125-022-05652-2. Epub 2022 Feb 15. Diabetologia. 2022. PMID: 35169870 Free PMC article.
-
Epigenome-wide association study of DNA methylation and microRNA expression highlights novel pathways for human complex traits.Epigenetics. 2020 Jan-Feb;15(1-2):183-198. doi: 10.1080/15592294.2019.1640547. Epub 2019 Jul 17. Epigenetics. 2020. PMID: 31282290 Free PMC article.
-
Blood DNA methylation signature of diet quality and association with cardiometabolic traits.Eur J Prev Cardiol. 2024 Jan 25;31(2):191-202. doi: 10.1093/eurjpc/zwad317. Eur J Prev Cardiol. 2024. PMID: 37793095 Free PMC article.
-
DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA1c levels: a systematic review and replication in a case-control sample of the Lifelines study.Diabetologia. 2018 Feb;61(2):354-368. doi: 10.1007/s00125-017-4497-7. Epub 2017 Nov 21. Diabetologia. 2018. PMID: 29164275 Free PMC article. Review.
-
Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.PLoS Med. 2023 Jul 6;20(7):e1004247. doi: 10.1371/journal.pmed.1004247. eCollection 2023 Jul. PLoS Med. 2023. PMID: 37410739 Free PMC article. Review.
Cited by
-
Causal Effects of Oxidative Stress on Diabetes Mellitus and Microvascular Complications: Insights Integrating Genome-Wide Mendelian Randomization, DNA Methylation, and Proteome.Antioxidants (Basel). 2024 Jul 26;13(8):903. doi: 10.3390/antiox13080903. Antioxidants (Basel). 2024. PMID: 39199149 Free PMC article.
-
Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.Front Endocrinol (Lausanne). 2024 Jan 22;15:1295967. doi: 10.3389/fendo.2024.1295967. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38323108 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical